一、王禹璇(陽明藥物科學所 臨床藥學組 碩二)
發表論文題目(壁報)：“Biomarker Interactions on Clinical Benefits of CDK 4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Patients”